CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
- 4 Conversion 10% owner acquired 1,931,852 shares (conversion)
- 4 Conversion Director acquired 6,000 shares (conversion)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Material agreement · Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
Page 15 of 21 · 406 filings